HACU-enhancing racetamsRacetam / HACUThe racetam nootropic family; several members facilitate high-affinity choline uptake (HACU) in cholinergic signalling.
Pramiracetam vs Coluracetam
The table compares the compounds’ key data from their entry pages. Open each compound’s full entry for details. Educational content, not medical advice.
| PPramiracetam | CColuracetam | |
|---|---|---|
| What it is | Potent cholinergic racetam, HACU enhancement + AMPA modulation. | Selective HACU enhancer (BCI-540), visual experience and antidepressant profile. |
| MechanismMechanism of actionThe molecular pathway by which a compound acts in the body (e.g. which receptor or enzyme it binds). | HACU + AMPA | Selective HACU activator |
| Half-lifeHalf-lifeThe time for the compound’s plasma concentration to fall by half; indicates how fast it clears and how often it is dosed. | 4-6 h | ~3 h |
| Legal statusLegal / WADA statusThe compound’s regulatory status (e.g. prescription) and its place on the WADA prohibited-in-sport list. | EU Rx (IT, withdrawn) | Investigational, no approval |
| Full entry | Open → | Open → |
What it is
PramiracetamPotent cholinergic racetam, HACU enhancement + AMPA modulation.
ColuracetamSelective HACU enhancer (BCI-540), visual experience and antidepressant profile.
MechanismMechanism of actionThe molecular pathway by which a compound acts in the body (e.g. which receptor or enzyme it binds).
PramiracetamHACU + AMPA
ColuracetamSelective HACU activator
Half-lifeHalf-lifeThe time for the compound’s plasma concentration to fall by half; indicates how fast it clears and how often it is dosed.
Pramiracetam4-6 h
Coluracetam~3 h
Legal statusLegal / WADA statusThe compound’s regulatory status (e.g. prescription) and its place on the WADA prohibited-in-sport list.
PramiracetamEU Rx (IT, withdrawn)
ColuracetamInvestigational, no approval
Full entry